Chocolate, brakes and CMD reflections
OPmobility, BMW, Eurofins, Carvolix, Knorr-Bremse, Indra Sistemas, Lindt & Sprüngli, Nestlé, TF1, Legrand, Groupe SEB
At Lux Opes, we break down companies into quick takes that get straight to the point - what is happening, why it matters, and what to watch next. We publish 2-3 times per week, depending on the news flow.
For the best reading experience, we recommend reading at Lux Opes
Financial KPIs
Companies covered in this edition: OPmobility, BMW, Eurofins, Carvolix, Knorr-Bremse, Indra Sistemas, Lindt & Sprüngli, Nestlé, TF1, Legrand, Groupe SEB

OPmobility (OPM France): A lighting deal that runs through Hyundai and Kia
● NEUTRAL
OPmobility buys Hyundai Mobis' lighting unit for KRW600bn, adding about 14% to group revenue; closing is not expected before late 2027.
On 30 September OPmobility signed for the whole of Hyundai Mobis' lamp business, at KRW600bn of enterprise value, or about €390m. Hyundai Mobis, Korea's biggest car parts maker, spun the lamp unit off into a separate company in April. The business has revenue of about KRW2.5tn, or €1.6bn, a positive operating margin and five plants across Korea, China, Mexico and the Czech Republic. Closing is expected in the second half of 2027, and OPmobility says the deal will not materially affect its deleveraging.
The size is meaningful. Against €11.5bn of economic revenue in 2025, our calculation shows the acquisition adding about 14% to the group. The effect inside Exterior & Lighting is much larger, since lighting is only part of a division that generated €2,634m in the first half, down 4.6%. Chief executive Félicie Burelle presents the deal as a way to deepen the partnership with Hyundai and Kia, which gives OPmobility a Korean industrial base and a customer relationship that would take years to build on its own.
The financing looks manageable. In the first half OPmobility generated €5,822m of economic revenue, an operating margin of 4.8%, or €251m, and €167m of free cash flow, and ended June with net debt of €1,319m. The price equals about 30% of that net debt by our calculation, and with payment not due until 2027, the group has time to build cash before it closes.
The unknowns are the margin of the acquired business, which is described only as positive, and how the unit will be run during almost two years under its current owner, which is also its main customer. As an illustration only, if the unit merely matched OPmobility's first-half margin of 4.8%, it would earn about €77m a year, a useful addition to a group that made €251m in six months. A higher margin would make the price look modest, a lower one would dilute the group. At c.0.24x sales, the price sits below OPmobility's own 0.3x 2026e EV/Sales and 3.2x 2026e EV/EBITDA, so the group is not paying up for the Hyundai relationship. We see the deal as a sensible move in lighting, but the earnings effect cannot be measured until OPmobility discloses more about the unit.
BMW (BMW Germany): Most of the margin repair comes after 2028
● NEGATIVE
BMW targets 8-10% automotive margins by the next decade, but its 3-5% goal for 2028 shows how slow the climb is.
Milan Nedeljkovic, chief executive since May, used his first capital market day on 30 September to set a ladder of targets. The Automotive EBIT margin should be 1-3% in 2026 with Automotive free cash flow above €2.5bn, 3-5% in 2028 with free cash flow above €5bn, and 8-10% by the start of the next decade with free cash flow of at least €7bn. Decisions on further measures are due by spring 2027. The cost levers announced so far are fewer model variants, no successor to the 2 Series Active Tourer, and 20% fewer divisions and management roles by mid-2027. Our arithmetic on the midpoints says the margin rises by two points between 2026 and 2028 and then by five points after that, so most of the recovery lies beyond the period covered by detailed measures.
China is where the plan changes most. BMW wants the share of cars it sells there that are built and tailored locally to reach at least 95% by 2030, from just under 90%, with imports limited to the highest-margin models. China-built cars may also be exported to Southeast Asia. That lowers tariff and currency exposure but also means accepting that the Chinese customer will no longer pay for a German-built premium car in volume.
On product, BMW plans a new SUV above the X7, more regional production because Spartanburg is running at full capacity, an entry-level Neue Klasse electric car in 2028 and wider use of AI in development and operations. Free cash flow doubling from the 2026 floor to the 2028 floor is the more concrete part of the plan, and it should come partly from lower capital spending once the Neue Klasse ramp is complete. The longer-range margin goal depends on decisions still to be made,
The ladder also shows how far cash has to travel. Automotive free cash flow of at least €7bn at the start of the next decade is 2.8 times the 2026 floor by our calculation. The measures named so far, cutting variants and management layers, reduce overhead and complexity, but the step from a 4% midpoint in 2028 to 9% will need decisions on capacity, model mix and pricing in China that BMW has said it will take only by spring 2027. Until those are on the table we remain cautious.
Eurofins (ERF France): Margins move before BioPharma does
● NEUTRAL
The EBITDA margin rose 130bp to 23.7% on 2.7% organic growth; the full-year growth goal now relies on the second half.
Eurofins improved profitability faster than sales in the first half. Revenue was €3,701m with organic growth of 2.7%. Adjusted EBITDA reached €877m, a margin of 23.7%, up 130 basis points and only 30 basis points short of the 24% target for 2027. Earnings per share rose 29% to €1.55.
The growth objective is now the harder one. Eurofins aims for mid-single-digit organic growth in 2026. If the two halves are similar in size, our calculation says a 5% year needs about 7.3% in the second half, and the 4-6% range requires 5.3-9.3%. BioPharma services remain slow, and management expects a pickup in the second half. That is a large step from 2.7%, so the full-year growth target depends on a recovery that has not yet appeared in the numbers.
Cash flow is stronger. Free cash flow to the firm before investment in owned sites came to €469m, a cash conversion rate of 47%, and net debt was €3,854m, or 2.2 times leverage. The group bought back 3.65m shares at an average of €63.04 during the half. Cash conversion below 50% still leaves room to improve once the investment in owned sites slows, and leverage at 2.2 times gives the group room to keep buying back shares and doing small deals at the same time.
The portfolio is moving at the same time. Eurofins completed 17 small acquisitions for €138m, agreed on 20 July to buy Element's life sciences testing activities and sold its electrical and electronics testing business to UL Solutions. Both portfolio moves add weight to life sciences, the area where growth is currently slowest, so the group's exposure to a BioPharma recovery is rising, not falling. The margin gains show that the cost work is delivering, and with 30 basis points left to find over the next six quarters the 2027 margin goal looks within reach. Earnings per share growing ten times faster than organic sales also shows how much of the progress came from efficiency. The second-half growth rate remains the open question for this year, and a miss there would mean the margin target is met on a smaller revenue base than planned.
Carvolix (CVX France): Funded into 2027, with three regulatory decisions ahead
● NEUTRAL
Cash burn almost doubled to €13.0m in the first half; the Claret facility stretches the runway to October 2027 if fully drawn.
Carvolix spent heavily in the first half to get its products ready for approval. The operating loss came to €14.4m, against €9.1m a year before, and the net result was a €13.9m loss. Cash burn rose to €13.0m from €6.8m, mainly because headcount went from 76 to 102 people and personnel costs reached €6.3m.
Funding has been put together in two steps. The company raised €19.6m net in equity during the half and still ended June with only €7.0m of cash. On 6 August it signed a €30m structured financing with Claret, made up of €20m of convertible notes and €10m of amortising debt, with maximum dilution of 8.6%. The first €10m has been drawn. Carvolix says this funds operations until February 2027, or until October 2027 if the whole facility is used.
We checked that against the burn rate. The first-half outflow works out at about €2.2m a month. June cash plus the first Claret tranche gives about €17m, which by our calculation lasts roughly eight months, consistent with the February date. The remaining €20m buys another eight or nine months at the same pace, but it is convertible money that dilutes holders, and spending is more likely to rise than fall once products launch.
The next twelve months are dense with decisions. Carvolix expects the CE mark for its TAVIPILOT Software before the end of 2026, with a European launch early in 2027. It has filed with the FDA for the robotic system and expects an answer early in 2027. For Kalios, all 15 patients followed for three years met the primary endpoint, and a US launch is targeted for 2027.
The board has also changed, with Anne Lange taking over as chair from Liane Teplitsky. Three regulatory events, a new chair and a runway measured in months make the coming year a binary one for a company of this size. Positive answers would make a further raise much easier, but delays at either the FDA or the notified body would leave the company raising capital from a weaker position.
Knorr-Bremse (KBX Germany): The second half has to carry the margin
● POSITIVE
Q2 margin reached 14.2% and truck orders grew; guidance implies a 14.1-15.1% margin in the second half.
Knorr-Bremse had a good second quarter. Revenue rose 7.2% to €2.143bn, 6.4% organically, operating EBIT reached €305m for a 14.2% margin, free cash flow was €262m and the order book stood at €7.887bn. For the half, revenue was €4,080m, operating EBIT €566m, a 13.9% margin, and free cash flow €294m. Subtracting the second quarter gives a first quarter of €1,937m revenue and €261m of operating EBIT, a 13.5% margin, so the improvement through the half was clear. Almost all of the half's cash, €262m of €294m, came in the second quarter.
The two divisions are moving in opposite directions on orders. Rail took €2,399m of orders in the half, below €2,600m a year earlier, but holds a backlog of €5,910m and earned €383m of EBIT, a 17.1% margin. Truck orders rose 7.5% to €2,026m, the backlog was €1,979m, and on €1,837m of revenue the division earned €214m, an 11.6% margin. Rail remains the profit engine, while truck is recovering from a low base. Group orders of €4,431m in the half compare with €4,080m of revenue, a book-to-bill ratio of about 1.09 by our calculation. Truck now represents about 45% of group revenue, so every point of truck margin improvement moves the group margin by close to half a point.
Full-year guidance stands at €8.1-8.3bn in revenue, with an operating margin between 14% and 14.5% and between €750m and €850m of free cash flow. Our arithmetic says that requires €568-638m of operating EBIT in the second half, a margin of 14.1-15.1%, and free cash flow of €456-556m, compared with €294m in the first half. The bottom of the range is close to the second-quarter run rate. The top needs a further step up, which the seasonal pattern of cash flow makes plausible but not certain.
The longer plan is ambitious. By 2030 Knorr-Bremse wants about €10bn of revenue, an operating margin of about 16%, cash conversion above 90% and return on capital employed above 25%. The portfolio is being adjusted to fit, with the Merak HVAC business sold to OpenGate and duagon acquired. With rail margins already above 17%, the 2030 goal depends mainly on truck margins improving, and the second-quarter figures support our positive view.
Indra (IDR Spain): A smaller top team for a much larger defence business
● NEUTRAL
Indra merges Defence and Space, removes five executives and cuts its committee to ten ahead of a 25 November strategy day.
On 29 September Indra announced a new management structure. Defence and Space become one unit under Juan Ramón Hernández Barrera. Five executives leave: Ausaverri, Escalante, Mora, Rodríguez Veiga and Panduro. The international directorate disappears into the business units, and air traffic management and mobility come under Víctor Martínez. Forteza takes on control and M&A, Santos becomes technical secretary-general and Frank Torres becomes chief operating officer. The strategy, technology and product role is vacant, with Recasens covering it on an interim basis, and the management committee shrinks to ten members.
The new structure follows the business. Defence revenue more than doubled in the first half, up 103%, and in the second quarter Defence made up 38% of group revenue against 43% for Minsait, 9% for air traffic management, 5.5% for Space and 5% for Mobility. Space fell 14% organically over the half, so putting it under the defence head ties a weak unit to the strongest one.
The group numbers have outgrown the old organisation. Backlog reached €20.533bn in June from €9.474bn a year earlier, a 117% increase by our calculation. Order intake rose 58% to €5.01bn, revenue 30% to €3.179bn, with organic growth of 16%, and EBIT reached €316m, a 9.9% margin. Free cash flow of €1.487bn left net cash of €1.033bn. That first-half cash flow is almost four times the full-year floor, so the target would still be met even if the second half absorbed about €1.1bn, which shows how lumpy cash is in large defence contracts.
The 2026 targets are revenue above €7bn, EBIT above €700m and free cash flow above €375m. Our arithmetic says the second half needs more than €3.82bn of revenue and €384m of EBIT, a margin of about 10%, close to the first half. Minsait, the IT business, is still the largest unit at 43% of second-quarter revenue, and its growth will matter for reaching the revenue target as much as defence. Backlog equals almost three years of target revenue, so the constraint is delivery capacity and management bandwidth. The capital markets day on 25 November should show whether the leaner team comes with new targets.
Lindt & Sprüngli (LISN Switzerland): Heat and price resistance cut the year
● NEGATIVE
Lindt cut 2026 organic growth guidance to 0-2% from 4-6%; the second half now looks flat to negative.
Lindt & Sprüngli cut its 2026 outlook on 29 September, two months after confirming it. Organic growth is now expected at 0-2%, against 4-6% before. The company blames consumers' sensitivity to higher prices and extreme summer heat, with seasonal weakness in Germany, Switzerland and Austria, while North America and Asia held up well. The EBIT margin is still expected to improve by 20-40 basis points, volume growth should return in 2027 and the mid-term targets from 2028 onwards are confirmed.
The first half already showed where the pressure was. Organic growth was 4.3%, all from price: pricing added 11.8% and volume and mix took away 7.5%. Europe fell 2.1%, while North America grew 12.7% and the rest of the world 10.2%, and the EBIT margin was 11.2%. The second half normally brings about 60% of annual sales because of Christmas. By our calculation, a 0-2% year means second-half organic growth between about minus 2.9% and plus 0.5%, so the guidance assumes no growth at all in the season that counts most. The previous range implied about 5.5% for the second half, so the cut amounts to a swing of almost seven points, all of it in the remaining months.
The margin promise is the part that holds, helped by cocoa costs that are normalising. But volumes have been falling while prices stayed high, and the company now asks for another year before they recover. That depends on retailers and consumers accepting the current price level, or on Lindt passing some of the lower cocoa cost back. Both routes postpone growth. The regional picture adds to the concern, since Europe was already shrinking in the first half and the heat-related weakness came in German-speaking markets, Lindt's European core. North America and the rest of the world kept growing at double-digit rates, but they cannot offset a weak Christmas in Europe. A margin improvement on lower growth also shows the company protecting profit at the cost of volume, which is the trade-off that delayed the volume recovery in the first place. On 25.7x 2026e P/E, barely lower at 24.2x for 2027e, Lindt is still rated for growth it has just guided away. We stay cautious until volumes turn.
Nestlé (NESN Switzerland): Volumes improve, the second half gets harder
● NEUTRAL
Real internal growth reached 1.8% in Q2, but full-year guidance implies 2.4-4.4% organic growth in the second half.
Nestlé's first half showed volume coming back to the centre of its growth. Organic growth was 3.6%, made up of 1.5% real internal growth and 2.1% pricing, and the second quarter was better on volume, with RIG of 1.8% and pricing of 1.9%. The underlying trading operating profit margin rose to 16.4% from 15.7% in the second half of 2025.
The geography is uneven. Emerging markets excluding China grew 7.1% organically, China was stable and developed markets managed RIG of only 0.6%. The infant formula recall also weighed, costing about 90 basis points of growth in the first quarter and 30 basis points in the second, which means part of the second-quarter improvement is the recall effect fading.
Guidance for organic growth of 3-4% leaves room for a slowdown. With halves of similar size, our calculation gives 2.4-4.4% for the second half, so the top end needs acceleration and the bottom end allows deceleration. The third quarter faces a comparison with RIG of 1.5% a year ago. Nestlé expects the second-half margin to be similar to the first and free cash flow above CHF9bn for the year, which by our arithmetic requires more than CHF5.6bn in the second half. Fuel for Growth has delivered CHF1.7bn of savings, with CHF2.0bn expected in 2026 and CHF3.0bn by 2027, and advertising and marketing has risen to 8.9% of sales. The step from CHF2.0bn to CHF3.0bn means a third of the planned savings arrives only in 2027.
The portfolio is being reshaped at the same time. The Peranel waters joint venture values that business at €4.9bn and should bring about CHF2.8bn of cash in the first half of 2027. Vitamins and supplements and ice cream are held for sale, a CHF1.3bn write-down was taken, and net debt stood at CHF56.3bn. Disposals reduce complexity and debt, but they also remove sales, so the volume trend in the remaining categories carries more weight than before. We see the half as a steady improvement, not yet enough to change our view of the year.
TF1 (TFI France): Streaming grows, linear advertising shrinks faster
● NEUTRAL
First-half operating profit fell to €77m as advertising dropped 8.7%; TF1+ grew 18.6% but is about 15% of advertising revenue.
TF1's first half was weaker than its second quarter. Revenue fell 6.4% like-for-like to €993m, and current operating profit from activities (COPA) dropped to €77m from €131m, a margin of 7.8% for the half against 12.3% in the second quarter alone. Advertising still makes up about 72% of group revenue by our calculation, so the group's profit is tied to a market that is shrinking.
Advertising is the cause. Group advertising revenue was €714m, down 8.7%, while TF1+ advertising rose 18.6% to €109m. Taking the streaming figure out, our calculation puts linear advertising at about €605m, down roughly 12%. TF1+ now accounts for about 15% of advertising revenue, so each point of linear decline still costs more than the streaming growth adds. On our estimates of the year-earlier figures, linear advertising lost about €85m while TF1+ advertising gained about €17m, a ratio of five to one.
Cost control helped but did not offset the gap. Programming costs fell €19m to €433m while COPA fell €54m. By our arithmetic the savings absorbed only about a quarter of the drop that would otherwise have hit profit. Programming still absorbs about 44% of revenue, so further savings are possible, but cutting too deep would weaken the audiences that feed TF1+. Studio TF1 added to the pressure, with revenue of €124m and a COPA loss of €4m.
The digital side is growing quickly. TF1+ reached 42m monthly streamers, with a record of 44m, and 8.3m daily streamers on 25 June. The distribution agreement with Netflix brings TF1 content to a wider audience, and digital revenue rose 17.1% to €134m, about 13.5% of group revenue by our calculation.
TF1 guides to a full-year margin in the mid-to-high single digits, which the first half already meets, and holds €432m of net cash. That cash leaves EV at c.€0.9bn, only 1.9x 2026e EBITDA, so the rating already assumes linear advertising keeps shrinking. The balance sheet gives the group time to keep investing in TF1+ while linear revenue shrinks. What it cannot yet show is the point at which streaming growth covers the decline in linear advertising.
Legrand (LR France): Data centres double the growth ambition
● POSITIVE
New 2027-30 targets call for 6-8% organic growth a year and a 21-22% margin, with data centres at 32% of sales.
Legrand used its capital markets day on 29 September to raise every growth number it gives. For 2027-30 it now targets organic sales growth of 6-8% a year, against 3-5% in the previous plan, plus about 5% a year from acquisitions. The adjusted operating margin goal moves to 21-22% from about 20%, and free cash flow should run at 13-15% of sales. The group also plans to dispose of activities with €0.5-1.0bn of sales, keeps a payout of about 50% and wants leverage between 1.5 and 2.5 times.
The upgrade comes from one end market. Data centres already make up 32% of sales and should pass €3bn in 2026, energy transition products another 22%, and what Legrand calls essential building infrastructure the remaining 46%. Management says the facilities it serves have about 80GW of capacity today and expects 180GW by 2030, which by our calculation is growth of roughly 22% a year. Products tied to the energy and digital transitions are 53% of sales and should reach about 70% by the end of the plan. The building side is assumed to stay slow, with European construction growing 1-3%.
Our arithmetic shows how acquisitive the plan is. Organic growth of 6-8% compounded with 5% from acquisitions gives total growth of about 11-13% a year before disposals. Spending about 60% of free cash flow on deals, at the target cash margin, means acquisitions absorbing around 8-9% of sales every year. The first half shows the model already running at that speed: organic growth of 9.8%, another 6.9% from acquisitions and a 20.8% adjusted margin, with Girtz among the companies added. Both growth rates are above the new annual ranges, so the plan asks Legrand to keep, not to accelerate, its current pace.
In our view the new targets are credible because the first half already sits inside them. The risk is concentration. With a third of sales in data centres and the bulk of growth expected from them, any slowdown in hyperscaler construction would hit both organic growth and the deal pipeline. The planned disposals should lift the mix, although the gain on the margin will depend on what is sold.
Groupe SEB (SK France): Profit recovers ahead of sales
● NEUTRAL
Operating result from activity rose 44% to €172m on 1.7% like-for-like growth, with savings, tariffs and FX doing most of the work.
Groupe SEB's first half showed a profit recovery without much help from sales. Revenue was €3,743m, up 1.7% like-for-like, while the operating result from activity (ORfA) rose 44% to €172m, a 4.6% margin. By our calculation that is an increase of about €53m on the prior year.
The bridge explains the gap. A tariff refund added about €15m, structure costs were €25m lower and currency contributed €12m. Together those three items add up to about €52m, so nearly the whole improvement came from costs, a one-off refund and FX, with little from volume or price.
Demand differs widely by region. Consumer sales were €3,268m, up 2.3%. North America grew 9.5%, and 15% in the second quarter, South America 6.1%, Western Europe 2.0% and China 1.3%, while other EMEA rose just 0.6% with a sharp fall in the Middle East. The Professional business, about 13% of group sales, fell 2.8% to €476m and 6.2% in the second quarter, although services are around 35% of that activity and SEB has gained a listing with McDonald's. North America growing fastest despite tariffs is a positive sign, but it is a smaller market for SEB than Western Europe, where growth of 2.0% leaves the group dependent on cost savings.
The Rebound plan is meant to make the cost side durable. It should deliver €40-60m of savings in 2026 and about €200m run-rate by 2027, with 25-30% of product references cut. The restructuring cost is visible: €178m of exceptional charges led to an attributable net loss of €124m. Free cash flow improved to €53m from minus €213m, but net debt is €2,516m, or 2.8 times, against a target of about two times by 2027. At constant EBITDA, our arithmetic says the leverage goal would require net debt to fall to about €1.8bn, so most of the deleveraging has to come from higher earnings. Equity is only c.53% of a €5.8bn EV, and the fall from 14.6x 2026e P/E to 7.8x 2027e shows how much of the rating rests on those earnings arriving. The €25m cut in structure costs in the first half compares with €40-60m of Rebound savings planned for the whole year, which gives a sense of how much is already in the numbers. The second half has to show savings carrying the result without a repeat of the tariff refund.